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(não houve diferença estatisticamente significante)
Radial artery versus saphenous vein to myocardial
revascularization: meta-analysis (there is no
statistically significant difference)
Abstract
      Objective: To compare the effectiveness of the radial
artery graft with the saphenous vein graft for myocardial
revascularization in association with the internal thoracic
artery.
     Methods: A systematic review of the literature was made,
searching for articles in the MEDLINE and LILACS
databases. Two independent researchers performed the
selection of articles, carefully evaluating the methodology
described in articles considered relevant to the subject. Only
controlled trials with an adequate randomization system were
included. In all situations, when the researchers did not reach
an agreement, a consensus meeting was held. No restrictions
were stipulated in respect to the follow-up period for the
angiographic evaluation of the graft, the vessel treated or the
characteristics of the patients included in the studies. The
results are expressed as Relative Risks (RR), with 95%
Confidence Intervals (CI) to compare the effectiveness
between the radial artery and the saphenous vein.
    Results: Based on these criteria, three studies were
included. We did not find statistical differences between the
patencies of the grafts (RR 0.53 [95% IC 0.13 – 2.18]).
     Conclusion: Despite the studies having good methodologies
we did not observe statistically significant differences between
the grafts. The statistical power of the meta-analysis is low
and therefore, more randomized controlled trials are
necessary, with adequate sample sizes to detect possible
differences between the different treatments.
   Descriptors: Radial artery. Saphenous vein. Myocardial
revascularization. Meta-analysis.
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INTRODUCTION
Coronary artery disease (CAD) is the main cause of death
in practically all countries around the world in spite of the
advances in clinical and surgical cardiology [1].
Coronary artery bypass grafting (CABG) is a well-
established procedure used to treat advanced CAD. Although
the results of this operation are excellent [2,3], long-term
benefits are influenced by the type of graft used. It is well
known that saphenous vein (SV) grafts, although they are
widely employed, have an unsatisfactory perviability over
the long-term. Around 15% of SV grafts occlude within the
first postoperative year [4], and only 50 to 60% of the grafts
are patent over ten years of the postoperative period [5,6].
Thus, the use of the internal thoracic artery (ITA) is,
without doubt, one of the most important advances in the
treatment of CAD over the last 25 years. These arteries are
associated with a better long-term angiographic perviability
when compared to SV grafts, promoting a significant
reduction in mortality [7-10]. In view of these results, the
use of the ITA became the gold standard for CABG, with the
SV utilized as complementary grafts for complete
revascularization.
On the other hand, the better results of arterial grafting
encouraged surgeons to explore other arteries to complement
the ITA aiming at substituting the SV grafts. Thus the
gastroepiploic artery [11-13], the inferior epigastric artery
[14] and the radial artery (RA) were investigated.
Of these, the RA is currently the most commonly used.
Initially described in 1973 by Carpentier et al. [15], the use of
the RA was abandoned soon after due to its susceptibility
to spasms and functional occlusion [16,27]. However, with
the advent of drugs that prevent spasms and the adoption
of better dissection techniques, interest for the RA as an
additional arterial conduit was revitalized in the 1990s [18].
Many institutions have reported that the RA can be used
with acceptable mortality and morbidity rates and that the
angiographical results are similar to those of the ITA [19-
27]. On the other hand, some published data present
limitations related to the long-term angiographical results
of these grafts.
A recent observational study by Khot et al. [28] in 2004,
showed a reduction in the perviability of RA grafts when
compared to ITA and SV grafts. Despite of being a study
with a low level of significance, with high potential of bias
in the selection and follow-up, there was a stir in the
credibility of surgeons who used RA grafts. Thus we
decided to perform a scientific metanalytic review of
publications to assess the effectiveness of the RA graft in
CABG comparing its patency with SV grafts when used in
association with the ITA graft.
METHOD
Inclusion criteria in the review study
Controlled and randomized or quasi-randomized clinical
trials that compared the perviability of RA and SV grafts in
association with ITA grafts were included. Double-blind
studies are not possible in this type of intervention however,
masking was assessed, but was not considered as a decisive
requisite for inclusion of studies.
Type of participants
Coronary disease patients, independently of age or
ethnic group who required CABG due to obstruction greater
than 70% in any coronary artery were included. The necessity
      Resumo
Objetivo: Comparar a efetividade do enxerto de artéria
radial com o enxerto de veia safena para revascularização do
miocárdio, em associação com a artéria torácica interna.
Método: Realizou-se uma revisão sistemática da
literatura, utilizando uma estratégia de busca de artigos
aplicada às bases de dados da MEDLINE e LILACS. Dois
pesquisadores independentes realizaram a seleção dos artigos
identificados, avaliando criteriosamente a metodologia dos
artigos considerados relevantes para o tema. Somente os
ensaios clínicos controlados e randomizados com adequado
sistema de aleatorização foram incluídos. Em todas as situações
em que ocorreu discordância entre os pesquisadores, foi
realizada uma reunião de consenso. Não foi estipulada
restrição quanto ao período pós-operatório para avaliação
angiográfica do enxerto, o vaso tratado cirurgicamente e as
características dos pacientes incluídos. Os resultados são
expressos como Risco Relativo (RR), com 95% de Intervalo de
Confiança (CI), da comparação da efetividade entre a artéria
radial e a veia safena.
Resultados: Com base nesses critérios foram incluídos
três estudos. Não foi detectada diferença estatística entre a
perviabilidade dos enxertos estudados (RR 0,53 [95% IC 0,13
- 2,18]).
Conclusão: Apesar dos estudos serem de boa qualidade
metodológica, não houve resultado estatisticamente
significativo beneficiando um dos enxertos. O poder
estatístico da metanálise é baixo. Portanto, são necessários
novos ensaios clínicos controlados e randomizados, com
tamanho de amostra adequado para detectar possíveis
diferenças entre os tratamentos propostos.
Descritores: Artéria radial. Veia safena. Revascularização
miocárdica. Metanálise.
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of revascularization was considered from clinical, laboratorial,
electrocardiographic and coronarographic signs and
symptoms of the patient.
Types of interventions
The perviability of RA and SV grafts was evaluated. The
number of grafts that each patient was submitted to was
considered rather than the number of patients.
Measured results
Occlusion of the vessel at 1 year and 5 years after the
surgical procedure.
Strategy to identify studies
The electronic databases of MEDLINE via PubMed and
LILACS via the Virtual Health Library were accessed up to
September 2005. The search strategy utilized was formulated
using key words relative to the review theme grouped in a
way to filter all the articles. The authors chose a highly
sensitive filtering strategy and restrictions in respect to the
publication language were not used thereby diminishing
publication bias.
Research strategy for MEDLINE
(Aortocoronary Bypass OR Aortocoronary Bypasses
OR Bypass, Aortocoronary OR Bypasses, Aortocoronary
OR Bypass Surgery, Coronary Artery OR Coronary Artery
Bypass Grafting OR Coronary Artery Bypass Surgery OR
Bypass, Coronary Artery OR Artery Bypass, Coronary OR
Artery Bypasses, Coronary OR Bypasses, Coronary Artery
OR Coronary Artery Bypasses OR CABG OR Coronary artery
bypass graft surgery OR CABG surgery OR Coronary Artery
Bypass, Off Pump OR Beating Heart Coronary Artery
Bypass OR Coronary Artery Bypass, Beating Heart OR Off-
Pump Coronary Artery Bypass OR Off Pump Coronary Artery
Bypass OR Off-pump coronary artery bypass graft surgery
OR Off pump coronary artery bypass graft surgery OR Off-
pump coronary artery bypass grafting OR Off pump
coronary artery bypass grafting OR OPCAB OR Off-pump
CABG surgery OR Off pump CABG surgery) AND ((Arteries,
Radial OR Artery, Radial OR Radial Arteries OR RA OR RA
conduit* OR RA graft* OR Radial arterial conduit* OR Radial
arterial graft* OR Radial aortocoronary bypass OR Radial
aortocoronary bypass graft* OR Radial by pass OR Radial
bypass OR Radial bypass graft* OR Radial bypass graft
surgery OR Radial bypass operation OR Radial bypass
surgery OR Radial conduit flap OR Radial conduits OR Radial
coronary OR Radial coronary anastomoses OR Radial
coronary bypass graft* OR Radial coronary bypass surgery)
AND (Saphenous Veins OR Vein, Saphenous OR Veins,
Saphenous OR SVG OR Saphenous allograft* OR
Saphenous aortocoronary bypass OR Saphenous
aortocoronary bypass graft* OR Saphenous by pass OR
Saphenous bypass OR Saphenous bypass graft* OR
Saphenous bypass graft surgery OR Saphenous bypass
operation OR Saphenous bypass surgery OR Saphenous
conduit flap OR Saphenous conduits OR Saphenous
coronary OR Saphenous coronary anastomoses OR
Saphenous coronary bypass graft* OR Saphenous coronary
bypass surgery)) AND (randomized controlled
trial[Publication Type] OR controlled clinical trial[Publication
Type] OR randomized controlled trials[MeSH Terms] OR
random allocation[MeSH Terms] OR double blind
method[MeSH Terms] OR single blind method[MeSH Terms]
OR clinical trial[Publication Type] OR clinical trials[MeSH
Terms] OR (clinical*[Text Word] AND trial*[Text Word]) OR
single*[Text Word] OR double*[Text Word] OR treble*[Text
Word] OR triple*[Text Word] OR placebos[MeSH Terms]
OR placebo*[Text Word] OR random*[Text Word] OR
research design[MeSH Terms] OR comparative study[MeSH
Terms] OR evaluation studies[MeSH Terms] OR follow-up
studies[MeSH Terms] OR prospective studies[MeSH Terms]
OR control*[Text Word] OR prospective*[Text Word] OR
volunteer*[Text Word]).
Research strategy for LILACS
(Aortocoronary Bypass OR Aortocoronary Bypasses
OR Bypass, Aortocoronary OR Bypasses, Aortocoronary
OR Bypass Surgery, Coronary Artery OR Coronary Artery
Bypass Grafting OR Coronary Artery Bypass Surgery OR
Bypass, Coronary Artery OR Artery Bypass, Coronary OR
Artery Bypasses, Coronary OR Bypasses, Coronary Artery
OR Coronary Artery Bypasses OR CABG OR Coronary artery
bypass graft surgery OR CABG surgery OR Coronary Artery
Bypass, Off Pump OR Beating Heart Coronary Artery
Bypass OR Coronary Artery Bypass, Beating Heart OR Off-
Pump Coronary Artery Bypass OR Off Pump Coronary Artery
Bypass OR Off-pump coronary artery bypass graft surgery
OR Off pump coronary artery bypass graft surgery OR Off-
pump coronary artery bypass grafting OR Off pump
coronary artery bypass grafting OR OPCAB OR Off-pump
CABG surgery OR Off pump CABG surgery) AND (Arteries,
Radial OR Artery, Radial OR Radial Arteries OR RA OR RA
conduit$ OR RA graft$ OR Radial arterial conduit$ OR Radial
arterial graft$ OR Radial aortocoronary bypass OR Radial
aortocoronary bypass graft$ OR Radial by pass OR Radial
bypass OR Radial bypass graft$ OR Radial bypass graft
surgery OR Radial bypass operation OR Radial bypass
surgery OR Radial conduit flap OR Radial conduits OR Radial
coronary OR Radial coronary anastomoses OR Radial
coronary bypass graft$ OR Radial coronary bypass surgery)
AND (Saphenous Veins OR Vein, Saphenous OR Veins,
Saphenous OR SVG OR Saphenous allograft$ OR
Saphenous aortocoronary bypass OR Saphenous
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aortocoronary bypass graft$ OR Saphenous by pass OR
Saphenous bypass OR Saphenous bypass graft$ OR
Saphenous bypass graft surgery OR Saphenous bypass
operation OR Saphenous bypass surgery OR Saphenous
conduit flap OR Saphenous conduits OR Saphenous
coronary OR Saphenous coronary anastomoses OR
Saphenous coronary bypass graft$ OR Saphenous coronary
bypass surgery) AND ((Pt randomized controlled trial) OR
(Pt controlled clinical trial) OR (Mh randomized controlled
trials) OR (Mh random allocation) OR (Mh double blind
method) OR (Mh single blind method) AND NOT (Ct animal)
AND NOT (Ct human and Ct animal) OR (Pt clinical trial) OR
(Ex E05.318.760.535$) OR (Tw clin$) AND (Tw trial$) OR (Tw
ensa$) OR (Tw estud$) OR (Tw experim$) OR (Tw investiga$)
OR (Tw singl$) OR (Tw simple$) OR (Tw doubl$) OR (Tw
doble$) OR (Tw duplo$) OR (Tw trebl$) OR (Tw trip$) AND
(Tw blind$) OR (Tw cego$) OR (Tw ciego$) OR (Tw mask$)
OR (Tw mascar$) OR (Mh placebos) OR (Tw placebo$) OR
(Tw random$) OR (Tw randon$) OR (Tw casual$) OR (Tw
acaso$) OR (Tw azar) OR (Tw aleator$) OR (Mh research
design) AND NOT (Ct animal) AND NOT (Ct human and Ct
animal) OR (Ct comparative study) OR (Ex E05.337$) OR
(Mh follow-up studies) OR (Mh prospective studies) OR
(Tw control$) OR (Tw prospectiv$) OR (Tw volunt$) OR (Tw




Two independent researchers selected the trials for
inclusion or exclusion after analyzing the titles and abstracts
of the studies identified using the search strategies. The
selected trials were compared and any discrepancy was solved
by discussion and consensus. Subsequently, the trials
included were independently evaluated by the two researchers
to ensure that they obeyed the stipulated inclusion criteria.
Finally, the articles selected for review were checked to prevent
the inclusion of duplicated data.
Quality of evaluation
Two researchers independently evaluated the quality of
the methods of the included studies. The enrolment of patients
was verified stipulating a classification of studies in categories,
in which category A (adequate random allocation and
described in the methodology of the study), B (random
allocation mentioned but not described in the methodology
of the study), C (inadequate random allocation) and D (non-
randomized study with allocation). Any difference of opinion
was solved by discussion and consensus.
Data Extraction
The data of the studies were independently extracted by
two researchers using a standard form. The forms were set up
based on data previously defined as relative to the theme.
When necessary, the authors of the primary studies were
contacted to add information or data in the results of their
studies.
Methodological quality of the included studies
All the included studies were randomized or quasi-
randomized, that is, only studies classified in categories A,
B and C were included. Studies from Category D were
excluded from this systematic review. Two studies were
classified in Category A (Dessai et al., 2004; Buxton et al.,
2003) [29,30] and one study was classified as Category B
(Muneretto et al., 2004) [31].
RESULTS
After extracting all the data relative to the studies,
evaluating their quality, they were plotted in the Review
Manager – RevMan 4.2.8 program – for analysis.
Comparisons of the effects between the two interventions
of interest were expressed as Relative Risk (RR) with a 95%
confidence interval (CI).
A total of 398 articles were selected from the MEDLINE
and LILACS databases. Of these,  only three corresponded
to the inclusion criteria of study type, that is, they were
controlled and randomized or quasi-randomized clinical trials.
The metanalysis of the studies, involved 116 grafts up
to the cutoff date of this systematic review is presented as
an analysis of subgroups in respect to the evaluation of the
patency of the grafts at 12 months and five years. The results
of the subgroup and overall metanalysis are presented in a
random model (Figure 1).
Thre is no statistical difference between the groups in
respect to patency at 12 months (RR 0.1 [95% CI 0.5 – 1.4])
or patency at five years (RR 2.75 [95% CI 0.31 – 24.52]). An
estimation of the overall effect does not give statistically
significant proportions of events between the two groups
when expressed as a RR (RR 0.53 [95% CI 0.13 – 2.18]).
DISCUSSION
CABG is, without doubt, the treatment of choice for
patients with severe CAD. This procedure requires vascular
grafts, both arterial and venous, with an aim of optimizing
blood irrigation of the myocardial tissue of the post-stenotic
regions. Thus, a series of studies have been carried out to
compare the efficacy of venous and arterial grafts. It has
been proven that the viability of left ITA grafts is greater than
grafts using the SV [7,9,10], which currently are utilized as a
complement to the ITA to achieve complete revascularization.
Thus, surgeons tried other arteries that may substitute SV
grafts. Currently, the RA is the most commonly employed and
most studied for this procedure in association with the ITA.
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It is well known that the patency of the graft,
independently of whether it is venous or arterial, depends
both on factors inherent to the patient such as the presence
of comorbidities (diabetes, dyslipidemia, arterial
hypertension and renal insufficiency), and on factors related
to the method of dissection, preservation and
pharmacological protection of the vessel and the
implantation technique used [10]. Additionally, the territory
of the target coronary vessel is also related to the higher or
lower patency of the graft [21].
A series of observational studies indicated that the
patency of RA grafts is greater than the SV [32,33]. On the
other hand, Khot et al. in 2004 concluded that the patency
of the RA grafts is worse than the patency of all other vessels
employed in CABG [28]. However, all of these studies were
not randomized or controlled but observational, whether
prospective or retrospective, and so they have little
reliability and are subject to a considerable amount of bias.
Thus, we performed a systematic review of publications to
evaluate the patency of RA grafts compared to SV grafts.
We followed a wide ranging objective without restricting
the postoperative period for the angiographic evaluation of
the graft, the involved vessel and the characteristics of the
patients included. This conduct was adopted to offset the
extreme lack of controlled and randomized clinical trials that
cover this theme. Only three randomized trials were included
in this systematic review. The databases investigated include
a considerable percentage of the most important periodicals
of cardiovascular surgery, showing that there is insignificant
bias of publication. The search strategy utilized was highly
sensitive, checking all the studies related to the theme. The
controlled and randomized or quasi-randomized trials were
chosen for inclusion in this systematic review as they had
the greatest reliability and level of
evidence with the lowest Type 1 (á) and
Type 2 (â) errors. Masking was not
demanded for inclusion and the number
of patent grafts were evaluated and not
the number of patients.
The randomized and controlled trial
by Dessai et al. [29] published in 2004,
compared the patency at 12 months of
RA and SV grafts. Its methodology is
reproducible and scientific with an
adequate method of randomization, and
a reasonable number of patients (n =
440). The angiographic evaluations
were pre-determined and the results
gave a higher patency for RA grafts
compared to SV grafts.
Muneretto et al. [30], also in a
publication from 2004, compared the
patency of RA and SV grafts over 12 months. The
angiographic results of 152 patents distributed into two
groups were evaluated. The number of participants is
relatively small, increasing the uncertainty of the results
and conferring a considerable confidence interval. The
methodology is reproducible, with pre-programmed
angiographs, however, the form of randomization of the
patients was not described. The authors concluded that the
RA graft has a better patency than the SV graft.
The other randomized controlled clinical trial was
performed by Buxton et al. [31] in 2003. These authors
recruited 438 patients who were randomized in two groups.
In the first, the 285 patients were randomized into two other
groups, one with 140 patients who received RA grafts and
the other of 145 patients received right ITA grafts. The
second group contained 153 patients who were randomly
distributed in two other groups, one with 73 patients who
received RA grafts and the other with 80 patients who
received SV grafts. The methodology is adequate with
programming of the angiographic evaluation of 40% of the
patients at five years and 60% of the patients at 10 years.
The number of patients was not adequate and the results at
five years did not give a significant difference between the
two groups with RA and SV grafts. The data of patency at
ten years are not available yet.
It is important to note that these clinical trials have a pre-
determined angiographic study in their methodology, even
if the patient does not present with ischemic symptoms.
Angiographic studies based on symptoms do not offer a
satisfactory representativity of the population, as the failure
rate of the grafts of these patients is expected to be high
[10]. Buxton et al. [10] in 2005 published a study whose
result stated that the patency of the ITA, RA and SV grafts
Fig. 1 - Subgroup and overall metanalysis. For 12-month patency and 5-year patency there
are no statistical significances between groups. The estimation of the overall effect does not
demonstrate statistically significant proportions of events between groups when expressed as
relative risks
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were higher in protocols in which the patients were evaluated
independently of the symptoms than those in which the
patients were submitted to angiographic examination due
to symptoms.
In the results, we present a graph of the overall effect,
edited in a random model. This model highlights the clinical
and methodological heterogeneities present in the studies,
showing them in the statistical calculations. However more
reliable results were expected, that showed the possible
aforementioned heterogeneities better as the included
studies were not homogeneous. The method to select the
patients, the diagnostic criteria, the form of angiographic
evaluation and the surgical procedures were not similar
among the included clinical trials. Thus, no significant
difference was observed between the effects of using RA
and SV grafts.
Nevertheless, although the included studies were good
quality with satisfactory values in the study quality scale of
Jadad et al. [34], the statistical power of this metanalysis is
low, as the number of accumulated grafts was very small (n
= 1116). Nonetheless, there is a greater proportion of patency
of the RA graft compared to the SV graft expressed in the
results of the random model. However, a convict affirmation
that the RA graft is better than the SV graft requires more
controlled and randomized clinical trials, involving an
expressive sample size following a standardized, uniform
and homogeneous methodology. The authors suggest that
the methodological design of future clinical trials should be
based on the publication of Fremes [35]. This methodology
with certain modifications can be utilized to direct a series
of controlled and randomized clinical trials.
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